Furthermore, in mice, increased expression of syndecan-1 is associated with a therapy-resistant blastic crisis clone of chronic myeloid leukemia, and its loss is associated with marked improvement in survival [25]. Here, SDC1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.